Viral use and mimicry of autophagy pathway and components
Viral use and mimicry of autophagy pathway and components
批准号:
10215472
负责人:
Karla Kirkegaard
金额:
$39.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-10 至 2022-07-31
关键词:
Animal ModelAntiviral AgentsAutophagocytosisAutophagosomeBacteriaBindingBirdsCRISPR/Cas technologyCell LineCell physiologyCellsCellular MembraneChimeric ProteinsCommunicable DiseasesComplexCoxsackie VirusesCytoplasmDataDefectDengueDengue InfectionDengue VirusDependenceDevelopmentDiseaseDrug PrescriptionsEatingEnterovirusEnterovirus 71EventFastingFlavivirusFosteringGene DeletionGene ProteinsGenesGeneticGoalsGrowthHealthHepatitis CHumanHuman poliovirusIndividualInfectionInnate Immune ResponseKnowledgeLaboratoriesLipidsLysosomesMalignant NeoplasmsMeasuresMediatingMembraneMicrobeMissionModelingMorphogenesisMorphologyNobel PrizeNonlyticOutcomeOutcomes ResearchParasitesPathogenesisPathway interactionsPharmaceutical PreparationsPositioning AttributeProcessProductionProteomicsPublic HealthPublishingRNA Virus InfectionsRNA VirusesRNA replicationRecommendationRecyclingResearchRoleSolid NeoplasmSurfaceTestingTranslationsUnited States National Institutes of HealthViralVirionVirusVirus DiseasesVirus ReplicationWorkZika Virusbaseburden of illnessexperimental studygenetic testinghuman diseaseinhibitor/antagonistinsightmimicrymouse modelnovelnutrient deprivationparticlepreventresponsetoolviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goals of this work are to determine the mechanisms by which components of the
autophagy pathway promote viral replication and spread and to identify targets for development
of non-toxic antiviral compounds. The canonical autophagy (self-eating) pathway, described by
recent Nobel Prize winner Yoshinori Ohsumi, is stimulated by nutrient deprivation and culminates
in the degradation of cytoplasmic contents, thus nourishing the starving cell. To this end,
dramatic cellular events such as massive lipid scavenging, growth of novel membranous
compartments, entrapment of cytoplasm by both concave and convex membrane curvature, and
fusion with lysosomes are accomplished within minutes. Numerous microbes, including
poliovirus and Dengue virus, have evolved to subvert segments of the cellular autophagy
pathway or its individual constituents to promote their infectious cycles. The precise individual
contributions of genes and proteins from autophagy pathways have not been identified for any of
these viruses. In the experiments proposed here, CRISPR/Cas9 technology will be used to
generate matched cell lines oblated for individual steps such as autophagy initiation, expansion
and curvature of the limiting membrane, and placement of crucial fusion protein LC3 on the
surface of the nascent autophagosome. Testing the effects of individual gene deletions on the
entry, translation, RNA replication and morphogenesis of poliovirus and dengue virus will reveal
which components of the autophagy pathway are usurped by these two representative positive-
strand RNA viruses.
The central hypothesis, based on preliminary results, is that poliovirus and dengue virus use
distinct steps and components of the cellular autophagy pathway for disparate purposes: RNA
replication and nonlytic spread for poliovirus, virion assembly and maturation for dengue virus.
The rationale of the proposed research is that, once the components and mechanisms of these
subversive events are identified, it will be feasible to target antiviral compounds to particular
molecules and processes. Not surprisingly, given the dependence of these viruses on autophagy
machinery, short periods of fasting greatly exacerbate pathogenesis in mouse models of both
poliovirus and dengue virus infection. This exacerbation is also observed in response to
commonly used medications known to stimulate autophagy. Rigorous genetic tests will be used
to determine whether this increased pathogenesis is indeed dependent on the cellular autophagy
pathway.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.
在免疫抑制患者中发现的变体肠病毒A71与硫酸乙酰肝素结合,并在B细胞耗尽的小鼠中表现出神经性。
DOI:
10.1016/j.celrep.2023.112389
发表时间:
2023-04-25
期刊:
Cell reports
影响因子:
8.8
作者:
[]
通讯作者:
Viral use and mimicry of autophagy pathway and components
-
批准号:9757678
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2018
-
负责人:Karla Kirkegaard
-
依托单位:
Viral use and mimicry of autophagy pathway and components
-
批准号:9975099
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2018
-
负责人:Karla Kirkegaard
-
依托单位:
Subversion of Autophagy Pathway and Constituents by RNA viruses
-
批准号:8697258
-
项目类别:
-
资助金额:$46.63万
-
财政年份:2013
-
负责人:Karla Kirkegaard
-
依托单位:
Inhibiting Cellular Autophagy to Thwart Dengue Virus Packaging and Replication
-
批准号:8505375
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2012
-
负责人:Karla Kirkegaard
-
依托单位:
Inhibiting Cellular Autophagy to Thwart Dengue Virus Packaging and Replication
-
批准号:8391666
-
项目类别:
-
资助金额:$23.57万
-
财政年份:2012
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7292758
-
项目类别:
-
资助金额:$78.94万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The cell biology of Theiler's virus persistence in CNS
-
批准号:7244401
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persisstence in CNS
-
批准号:7144321
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7195852
-
项目类别:
-
资助金额:$78.25万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7660318
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The cell biology of Theiler's virus persistence in CNS
-
批准号:7450864
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persistence in CNS
-
批准号:7635920
-
项目类别:
-
资助金额:$61.47万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
The Cell Biology of Theiler's Virus Persistence in CNS
-
批准号:7880050
-
项目类别:
-
资助金额:$31.95万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7914217
-
项目类别:
-
资助金额:$79.0万
-
财政年份:2006
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6860089
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6632366
-
项目类别:
-
资助金额:$27.22万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6887625
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6232924
-
项目类别:
-
资助金额:$27.15万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
Viruses And Cells Gordon Conference
-
批准号:6359845
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
PICORNAVIRAL 3A PROTEINS AND HOST PROTEIN SECRETION
-
批准号:6511404
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2001
-
负责人:Karla Kirkegaard
-
依托单位:
海外基金